IBN EL ALAMI ET AL.
1H NMR (CDCl3) : d = 9.82 (1H, OH); 8.52 (1H, d, J= 4.5 Hz, C6H4N); 7.61
NMR 13C (APT, CDCl3) : d = 171.58 (CN); 142.85 (Cq-CH2); 135.25
(Cq-Ph); 129.17, 128.66, 128.21 (C6H5); 114.24 (Cq (p-cym); 109.89
(CH2); 96.46 (Cq (p-cym)); 87.46, 84.70, 81.36, 80.82 (4 CH (p-cym));
68.86 (Cq-NH); 55.04 (CH2-Ph); 39.22 (CH2-CH-CH2); 34.15 (CH2);
31.26 (CH(CH3)2); 29.41 (CH2); 24.36 (CH2); 23.47 (CH(CH3)2); 22.05
(CH3-CNH); 21.15 (CH3-C); 20.50 (CH(CH3)2); 18.98 (CH3 (p-cym)).
(1H, td, J = 1.1 Hz, C6H4N); 7.30 (1H, d, J = 7.8 Hz, C6H4N); 7.13 (1H, t, J = 5.8
Hz, C6H4N); 4.77 (2H, d, J = 8.1 Hz, CH2); 3,88 (1H, d, J = 14.2 Hz, CH2Py),
3.62 (1H, d, J = 14.3 Hz, CH2Py); 3.30 (1H, d, J = 13.1 Hz, CH2); 1.98
(1H, d, J = 12.3 Hz, CH2); 1.6–2.4 (m, 5H); 1,77 (s, 3H, CH3-CCH2); 1,34
(s, 3H, CH3-CNH).
13C NMR (CDCl3) : d =20.69 (CH3-C); 23.25 (CH3-CNH); 25.31 (CH2);
26.12 (CH2); 40.37 (CH2); 44.71 (CH-C); 47.86 (CH2NH); 56.49 (Cq-NH);
109.46 (CH2); 121.82, 122.38, 136.51, 148.60 (4 CH); 148.92 (Cq-CH); 159.91
(Cq (Py)); 162.19 (CN).
Complex 6b
To
a mixture of [Ru(p-cymene)Cl2]2 (76.5 mg, 0.125 mmol) and
benzylamino-oxime 4b ligand (68 mg, 0.25 mmol) in 10 ml of
dichloromethane, KOH (0.275 mmol) was added. After 4 h stirring at ambient
temperature, the orange solution was filtered, and KCl was eliminated. Upon
evaporation of the solvent, 6b was obtained as an orange powder. Yield: 70%
NMR 1H (CDCl3) : d = 7.2–7.6 (5H, m, C6H5); 6.11 (1H, d, J = 6 Hz, CH
(p-cym)); 5.92 (1H, d, J = 6 Hz, CH (p-cym)); 5.62 (1H, d, J = 6 Hz, CH
(p-cym); 5.44 (1H, d, J = 6 Hz, CH (p-cym)); 4.85 (2H, m, CH2NH); 4.66
(2H, d, J = 15 Hz, CH2); 4.03 (1H, s, NH); 3.61 (1H, d, J = 18Hz, CH2); 2.66
(1H, spt, CH(CH3)2); 2.39 (1H, m, CH); 2.17 (1H, dd, J = 6.1Hz, CH2);
2.00 (3H, s, CH3 (p-cym)); 1.2–1.9 (4H, m, 2 CH2); 1.58 (3H, s, CH3); 1.51
(3H, s, CH3); 1.09 (3H, d, J = 9 Hz, (CH3)2CH); 0.87 (3H, d, J = 9 Hz,
(CH3)2CH).
Anal. calculated for C16H23N3O: C, 70.30; H, 8.48; N, 15.37. Found:
C, 69.75; H, 8.85; N, 14.97.
Complex 5a
Phenylamino-oxime 4a ligand (136 mg; 0.527 mmol) and [RuCl2
(p-cymene)]2 (0.161 g; 0.263 mmol) were stirred for 30 min in 7 ml of
anhydrous dichloromethane. Diethyl ether (7ml) was then added drop by
drop, and the mixture was stirred overnight at ꢀ5 ꢁC. After filtration, the
crude product was concentrated under vacuum to give complex 5a as a
yellow powder. Yield: 65%.
1H NMR (CDCl3, 300 MHz): d = 12.46 (s, 1H, OH); 6.90–7.95 (m, 5H,
C6H5); 6.44 (d, J = 6Hz, 1H, CH (p-cym)); 6.31 (d, J= 6 Hz, 1H, CH
(p-cym)); 5.99 (d, J= 6 Hz, 1H, CH (p-cym)); 5.40 (s, 1H, NH); 4.74
(d, 1H, J=8 Hz, CH (p-cym)); 4.72 (s, 1H, CH2); 4.57 (s, 1H, CH2); 3.7
(d, J= 15Hz, 1H, CH2); 2.79 (st, 1H, CH(CH3)2); 2.49 (m, 1H, CH);
2.35–2.41 (m, 1H, CH2); 2.36 (s, 3H, CH3); 1.3–1.9 (m, 4H); 1,81 (s, 3H,
CH3); 1,56 (s, 3H, CH3); 1.07 (d, J=6Hz, 3H, (CH3)2CH); 0,57 (d, J=6Hz,
3H, (CH3)2CH).
NMR 13C (CDCl3) : d = 164.37 (CN); 143.79 (CqCH2); 136.01 (Cq-C6H5);
128.88, 128.42, 128.16 (CH(p-cym)); 113.49 (CH2); 108.32 (Cq(p-cym)); 96.37
(Cq(p-cym)); 87.74, 83.59, 81.79, 81.55 (CH(p-cym)); 68.45 (Cq-NH); 54.93
(CH2NH); 39.34 (CH); 34.33 (CH2); 31.10 (CH(CH3)2); 29.69 (CH2); 24.62
(CH2); 23.98 (CH(CH3)2); 22.20 (CH3); 21.18 (CH3); 20.10 (CH(CH3)2);
18.60 (CH3 (p-cym)).
X-ray crystallography, an irregular yellow plate-like specimen of
C54H74N4O2Ru2, approximate dimensions of 0.12 ꢂ 0.14 ꢂ 0.16 mm,
was used for the X-ray crystallographic analysis. The integration of the
data using an orthorhombic unit cell yielded a total of 14,148 reflections
to a maximum angle of 26.3ꢁ, of which 10,577 were independent
(completeness = 98.3%, Rint = 5.50%). The final cell constants of a = 8.8793
(11) Å, b = 22.171 (3) Å, c = 18.394 (2) Å, b = 90.627 (5)ꢁ, and volume =
3620.8 (8) Å3 are based upon the refinement of the XYZ centroids of
9823 reflections with 6ꢁ < 2 < 52ꢁ. Data were corrected for absorption
effects using the multiscan method (SADABS).
The structure was solved by Charge Flipping Method using Superflip
software37 and refined using the CRYSTALS Software Package38, using
the space group P21, with Z = 4 for the formula unit, C54H74N4O2Ru2.
In the final cycles of refinements, the contribution to electron density
suggested that part of solvent was highly disordered; attempts to model
this disorder were unsuccessful. In the final cycles of refinement, the
contribution to electron density corresponding to the disordered solvent
was removed from the observed data using the SQUEEZE option in
PLATON.39 The resulting data significantly improved the accurateness
of the geometric parameters for the remaining structure. The final
anisotropic full-matrix least-squares refinement on F with 578 variables
converged at R = 0.062 for the observed data and wR = 0.056 for all data.
The goodness-of-fit was 0.99.
13C NMR (CDCl3, 300 MHz) : d = 171.93 (CN); 167.25 (C6H5); 143.28
(C-NH); 142.70 (CCH2); 105.80 (p-cym); 124.00; 124.73; 127.89; 129.46;
130.15 (Ph); 113.83 (CH2); 105,8 (p-cym)); 97.56 (p-cym); 81.07; 84.81;
86.33; 86.55 (p-cym); 39.21 (CH); 34.60 (CH2); 30.48 (CH(CH3)2); 28.43
(CH2); 24.09 ((CH3)2CH); 23.94 (CH2); 22.86 (CH3); 22.07 (CH3); 18.79
(CH3); 18.41 ((CH3)2CH).
X-ray crystallography, a lustrous pale yellow plate-like specimen of
C28H38Cl8N2ORu, approximate dimensions of 0.07 ꢂ 0.23 ꢂ 0.27 mm,
was used for the X-ray crystallographic analysis. The integration of the
data using an orthorhombic unit cell yielded a total of 32,454 reflections
to a maximum angle of 23.46ꢁ, of which 5163 were independent
(completeness = 98.8%, Rint = 6.59%). The final cell constants of a = 9.5362
(15) Å, b = 15.604(3) Å, c = 23.905(4) Å, and volume = 3557.1(10) Å3 are
based upon the refinement of the XYZ centroids of 229 reflections above
20 s(I) with 4.338ꢁ < 2 < 30.68ꢁ. Data were corrected for absorption
effects by using the multiscan method (SADABS).
The structure was solved by Charge Flipping Method using Superflip
software37 and refined using the CRYSTALS Software Package,38 using
the space group P212121, with Z = 4 for the formula unit, C28H38Cl8N2ORu.
In the final cycles of refinements, the contribution to electron density
suggested that part of solvent was highly disordered; attempts to model this
disorder were unsuccessful. In the final cycles of refinement, the contribu-
tion to electron density corresponding to the disordered solvent was
removed from the observed data using the SQUEEZE option in PLATON.39
The resulting data significantly improved the accurateness of the geometric
parameters for the remaining structure. The final anisotropic full-matrix
least-squares refinement on F with 281 variables converged at R = 0.091
for the observed data and wR = 0.087 for all data. The goodness-of-fit
was 1.02.
Complexes 7b/7b 0
[Ru(p-cymene)Cl2]2 (76.5 mg; 0.125 mmol) and benzylamino-oxime 4b
ligand (68 mg; 0.25 mmol) in 5 ml isoPrOH were stirred for 30 min at
80 ꢁC. A solution of KOH in iPrOH (4.13 ml, 0.12 M) was added to the
reaction mixture. After stirring for 15 min, the solution was evaporated
under vacuum at 0 ꢁC to give a red powder. Yield: 91%.
NMR 1H (C6D6): d = 7.00–7.40 (5H, m, C6H5); 5.29, 5.02, 4.86, 4.64
(4H, 4d, J = 6 Hz, (p-cym)); 5.00 (1H, NH); 4.05–4.45 (4H, m, CH2Ph +
CH2); 2.46 (1H, spt, CH(CH3)2); 2.18 (1H, m, CH); 1.83 (3H, s, CH3
(p-cym); 1.15–1.65 (4H, m, 2 CH2); 1.48 (3H, dd, J = 1.5, 6 Hz, CH3); 1.14
(3H, d, J = 4.5 Hz (CH3)2CH)); 1.12 (3H, d, J = 4.5 Hz, (CH3)2CH));
ꢀ5.10 and ꢀ6.15 (Ru-H).
Complex 5b
Similar procedure as 5a using benzylamino-oxime 4b. Yield : 81%
1H NMR (CDCl3) : d = 12.19 (s, 1H, OH); 7.2–7.6 (m, 5H, C6H5), 5.96
(d, 1H, J = 5.9 Hz, p-cym); 5.86 (d, 1H, J = 5.7 Hz, p-cym); 5.76 (d, 1H,
J = 6.5 Hz, p-cym); 5.39 (d, 1H, J = 5.97 Hz, p-cym); 4.68 (m, 2H, CH2-);
4.58 (m, 2H, CH2-NH); 4.05 (singlet large, 1H, NH); 3.64 (d, 1H1,
J = 16.6 Hz, CH2); 2.67 (spt, 1H, J = 7.2 Hz, CH(CH3)2); 2.41 (singlet
large, 1H, CH-CH2); 2.29 (dd, 1H1, J = 6 Hz, CH2); 2.7 (s, 3H, CH3
(p-cym)); 1.30–2.01 (m, 4H, CH2); 1.59 (s, 3H, CH3-CCH2); 1.51 (s, 3H,
CH3-C-NH); 1.16 (d, 3H, J = 7 Hz, (CH3)2-CH (p-cym); 0.90 (d, 3H, J = 6.9
Hz, (CH3)2-CH).
Typical Transfer Hydrogenation Procedure
The catalysts were generated in situ prior to catalysis by heating a
mixture of the [RuCl2(arene)2]2 complex (0.01 mmol) with the desired
amino-oxime (0.04 mmol, 2 eq per Ru) at 80 ꢁC for 20 min in dry propan-
2-ol (5 ml). Then, a solution of the substrate (2 mmol) in propan-2-ol was
Chirality DOI 10.1002/chir